159 related articles for article (PubMed ID: 10730571)
1. Therapy of chronic viral hepatitis: a critical view.
Rizzetto M
Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):781-93. PubMed ID: 10730571
[TBL] [Abstract][Full Text] [Related]
2. Therapy for chronic hepatitis B. Present status.
Rizzetto M
Minerva Gastroenterol Dietol; 2000 Mar; 46(1):1-6. PubMed ID: 16498343
[TBL] [Abstract][Full Text] [Related]
3. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
[TBL] [Abstract][Full Text] [Related]
5. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.
Serfaty L; Thabut D; Zoulim F; Andreani T; Chazouillères O; Carbonell N; Loria A; Poupon R
Hepatology; 2001 Sep; 34(3):573-7. PubMed ID: 11526544
[TBL] [Abstract][Full Text] [Related]
6. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
[TBL] [Abstract][Full Text] [Related]
7. Review article: Nucleoside analogues for the treatment of chronic hepatitis B.
Younger HM; Bathgate AJ; Hayes PC
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1211-30. PubMed ID: 15606384
[TBL] [Abstract][Full Text] [Related]
8. Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy.
Suzuki F; Tsubota A; Akuta N; Someya T; Kobayashi M; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Miyakawa Y; Kumada H
J Gastroenterol; 2002; 37(11):922-7. PubMed ID: 12483247
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of chronic hepatitis B].
Marcellin P; Asselah T; Boyer N
Rev Prat; 2005 Mar; 55(6):624-32. PubMed ID: 15913114
[TBL] [Abstract][Full Text] [Related]
10. Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection.
Mutimer D; Dowling D; Cane P; Ratcliffe D; Tang H; O'Donnell K; Shaw J; Elias E; Pillay D
Antivir Ther; 2000 Dec; 5(4):273-7. PubMed ID: 11142622
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic hepatitis B: interferon alfa first.
Prescrire Int; 2001 Feb; 10(51):17-21. PubMed ID: 11503853
[TBL] [Abstract][Full Text] [Related]
12. Interferon/long-term lamivudine combination therapy in anti-HBe positive chronic hepatitis B patients.
Nikolaidis NL; Giouleme OI; Tziomalos KA; Saveriadis AS; Grammatikos N; Doukelis P; Voutsas AD; Vassiliadis T; Patsiaoura K; Orfanou-Koumerkeridou E; Balaska A; Eugenidis NP
J Gastroenterol Hepatol; 2005 Nov; 20(11):1721-5. PubMed ID: 16246192
[TBL] [Abstract][Full Text] [Related]
13. [Therapy effect of lamivudine combination with alpha interferon on patients with chronic hepatitis B].
Deng H; Zhao ZX; Xu QH; Zhou YP; Chen YM; Yao JL
Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):305-8. PubMed ID: 12773249
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between core gene mutations of hepatitis B virus and response to alpha interferon therapy in chronic hepatitis B].
Yoo BC; Kim HJ; Do JH; Park SM
Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):381-8. PubMed ID: 12506242
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis B: a wider range of therapeutic options.
Prescrire Int; 2007 Aug; 16(90):157-62. PubMed ID: 17724844
[TBL] [Abstract][Full Text] [Related]
16. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.
Yalcin K; Degertekin H; Yildiz F; Kilinc N
J Gastroenterol; 2003; 38(8):796-800. PubMed ID: 14505137
[TBL] [Abstract][Full Text] [Related]
17. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
[TBL] [Abstract][Full Text] [Related]
18. [Standard hepatitis B therapy].
Gerken G
Praxis (Bern 1994); 2000 Aug; 89(33):1283-6. PubMed ID: 11014127
[TBL] [Abstract][Full Text] [Related]
19. [Chronic hepatitis B. Recent advances in diagnosis and treatment].
Bernardi M; Biselli M; Gramenzi A
Recenti Prog Med; 2002; 93(7-8):397-402. PubMed ID: 12138683
[TBL] [Abstract][Full Text] [Related]
20. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
